A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies

SARS-CoV-2, the cause of the COVID-19 pandemic, has provoked a global crisis and death of millions of people. Several serological assays to determine the quality of the immune response against SARS-CoV-2 and the efficacy of vaccines have been developed, among them the gold standard conventional viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi-Estopiñan, Franciscary, Pérez, María Teresa, Fraga, Anitza, Bergado, Gretchen, Díaz, Geidy D., Orosa, Ivette, Díaz, Marianniz, Solozábal, Joaquín Antonio, Rodríguez, Laura Marta, Garcia-Rivera, Dagmar, Macías, Consuelo, Jerez, Yanet, Casadesús, Ana V., Fernández-Marrero, Briandy, Bermúdez, Ernesto, Plasencia, Claudia A., Sánchez, Belinda, Hernández, Tays
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856731/
https://www.ncbi.nlm.nih.gov/pubmed/35193792
http://dx.doi.org/10.1016/j.vaccine.2022.02.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856731/
https://www.ncbi.nlm.nih.gov/pubmed/35193792
http://dx.doi.org/10.1016/j.vaccine.2022.02.044

Ejemplares similares